Related Experiment Video
Updated: Jun 12, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Clinical tuberculosis and treatment outcomes
1Tuberculosis Unit, Liverpool Heart and Chest Hospital, Liverpool, UK. tsjordanhome@yahoo.co.uk
Summary
Global tuberculosis (TB) control efforts exceeded the 85% treatment success target in 2007. This review examines TB treatment outcomes from articles published in 2009.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Global Health
Background:
- The World Health Assembly set global tuberculosis (TB) control targets in 1991, aiming for 70% detection and 85% cure rates for new sputum smear-positive cases.
- The Directly Observed Treatment, Short-course (DOTS) strategy became central to TB control, underpinning the Stop TB Strategy and its Global Plan (2006-2015).
- Key goals included achieving the TB-related Millennium Development Goal (MDG) and reducing TB prevalence and mortality by 50% by 2015.
Purpose of the Study:
- To review articles on tuberculosis treatment outcomes published in the International Journal of Tuberculosis and Lung Disease in 2009.
- To assess the effectiveness of TB control strategies through treatment success and case detection rates.
Main Methods:
- Literature review of articles published in 2009.
- Analysis of outcome indicators such as treatment success and case detection rates.
- Focus on studies related to tuberculosis treatment outcomes.
Main Results:
- Globally, the treatment success rate for smear-positive TB cases surpassed the World Health Assembly's target of 85% for the first time in 2007.
- The review specifically analyzes treatment outcomes reported in 2009.
Conclusions:
- Global TB control efforts demonstrated progress, exceeding key treatment success benchmarks.
- Continued monitoring of treatment outcomes is crucial for evaluating and refining TB control strategies.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...